• 1
    Foulis, A. K. and Stewart, J. A., The pancreas in recent-onset type 1 (insulin-dependent) diabetes mellitus: insulin content of islets, insulitis and associated changes in the exocrine acinar tissue. Diabetologia 1984. 26: 456461.
  • 2
    Astorri, E., Bombardieri, M., Gabba, S., Peakman, M., Pozzilli, P. and Pitzalis, C., Evolution of ectopic lymphoid neogenesis and in situ autoantibody production in autoimmune nonobese diabetic mice: cellular and molecular characterization of tertiary lymphoid structures in pancreatic islets. J. Immunol. 2010. 185: 33593368.
  • 3
    Penaranda, C., Tang, Q., Ruddle, N. H. and Bluestone, J. A., Prevention of diabetes by FTY720-mediated stabilization of peri-islet tertiary lymphoid organs. Diabetes 2010. 59: 14611468.
  • 4
    Brinkmann, V., Cyster, J. G. and Hla, T., FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am. J. Transplant 2004. 4: 10191025.
  • 5
    Graham, K. L., Krishnamurthy, B., Fynch, S., Mollah, Z. U., Slattery, R., Santamaria, P., Kay, T. W. et al., Autoreactive cytotoxic T lymphocytes acquire higher expression of cytotoxic effector markers in the islets of NOD mice after priming in pancreatic lymph nodes. Am. J. Pathol. 2011. 178: 27162725.
  • 6
    Maki, T., Gottschalk, R. and Monaco, A. P., Prevention of autoimmune diabetes by FTY720 in nonobese diabetic mice. Transplantation 2002. 74: 16841686.
  • 7
    Schwab, S. R. and Cyster, J. G., Finding a way out: lymphocyte egress from lymphoid organs. Nat. Immunol. 2007. 8: 12951301.
  • 8
    Verdaguer, J., Yoon, J. W., Anderson, B., Averill, N., Utsugi, T., Park, B. J. and Santamaria, P., Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains. J. Immunol. 1996. 157: 47264735.
  • 9
    Chong, M. M., Chen, Y., Darwiche, R., Dudek, N. L., Irawaty, W., Santamaria, P., Allison, J. et al., Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction. J. Immunol. 2004. 172: 57145721.
  • 10
    Dudek, N. L., Thomas, H. E., Mariana, L., Sutherland, R. M., Allison, J., Estella, E., Angstetra, E. et al., Cytotoxic T-cells from T-cell receptor transgenic NOD8.3 mice destroy beta-cells via the perforin and Fas pathways. Diabetes 2006. 55: 24122418.
  • 11
    Wakim, L. M., Gebhardt, T., Heath, W. R. andCarbone, F. R., Cutting edge: local recall responses by memory T cells newly recruited to peripheral nonlymphoid tissues. J. Immunol. 2008. 181: 58375841.
  • 12
    Hamilton-Williams, E. E., Palmer, S. E., Charlton, B. andSlattery, R. M., Beta cell MHC class I is a late requirement for diabetes. Proc. Natl. Acad. Sci. U.S.A. 2003. 100: 66886693.
  • 13
    Sarukhan, A., Bedossa, P., Garchon, H. J., Bach, J. F. and Carnaud, C., Molecular analysis of TCR junctional variability in individual infiltrated islets of non-obese diabetic mice: evidence for the constitution of largely autonomous T-cell foci within the same pancreas. Int. Immunol. 1995. 7: 139146.
  • 14
    Wang, J., Tsai, S., Shameli, A., Yamanouchi, J., Alkemade, G. and Santamaria, P., In situ recognition of autoantigen as an essential gatekeeper in autoimmune CD8+ T-cell inflammation. Proc. Natl. Acad. Sci. U.S.A. 2010. 107: 93179322.
  • 15
    Neijssen, J., Herberts, C., Drijfhout, J. W., Reits, E., Janssen, L. and Neefjes, J., Cross-presentation by intercellular peptide transfer through gap junctions. Nature 2005. 434: 8388.
  • 16
    Wakim, L. M. and Bevan, M. J., Cross-dressed dendritic cells drive memory CD8+ T-cell activation after viral infection. Nature 2011. 471: 629632.
  • 17
    Coppieters, K. T., Dotta, F., Amirian, N., Campbell, P. D., Kay, T. W., Atkinson, M. A., Roep, B. O., et al.Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J. Exp. Med. 2012. 209: 5160.
  • 18
    Thomas, H. E., Parker, J. L., Schreiber, R. D. and Kay, T. W., IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes. J. Clin. Invest. 1998. 102: 12491257.